Thromboembolism in Pregnancy
Contributor: John Dacus, MD
Last Update: 5/1/2010
Deep venousthrombosis (DVT) during pregnancy
- Only 50% correctlyidentified with suspected clinical findings
- Diagnosticstudies
- Duplex doppler ultrasoundimaging
Proximal DVT – 98% sensitivity and 95% specificity
Distal DVT(calf) – 50% sensitivity
Repeat examination in 5-7 days increases sensitivity(especially calf) - Computerized tomography(CT) or magnetic resonance imaging (MRI) may be more helpful with pelvicthrombophlebitis or ovarian veinthrombosis.
- Duplex doppler ultrasoundimaging
Pulmonaryembolism during pregnancy
- Symptoms – tachypnea, tachycardia, hemoptysis, diaphoresis, fever, dyspnea,pleuritic chest pain, cough
- Diagnostic studies
- Laboratory – arterial p 02<85mmHg. EKG with sinus tachycardia, R axis shift. Chest film.
- 4 – channel multidetector spiral CT is the procedure ofchoice.
Treatment(Therapeutic infractionated heparin or therapeutic Lovenox ) of DVT or PulmonaryEmbolism
- Unfractionated Heparin
- Initial IV bolus of 80U/Kg followed by 18 U/Kg to achieve a PTT of 1.5 to 2.5 normal or antifactor Xaof 0.3 to 0.7 u/ml after 24 hours.
- Maintain IV heparin 7-10days.
- Switch to subcutaneousheparin dosing q 12 hours to achieve a PTT of 1.5 to 2.5 times of control orantifactor Xa of 0.3 to 0.7 u/ml 6 hours after AMinjection.
- Low molecular weightheparin (Lovenox or Fragmin)
- Lovenox 1.0 mg/kgsubcutaneous q 12 hours or Fragmin 100u/Kg q 12 hours.
- Maintain antifactor X alevel 4 hours after AM dose to 0.5 to 1.2 u/mlrange.
- Platelet count in 7-10days after heparin begins.
- Prenatal vitamin toinsure additional Vitamin D.
- Tums with 500 mg calcium(or equivalent) 3 times per day.
References
Phelan JP. Thromboembolicdisease (chapter 19). Critical care obstetrics. Library of Congresscataloging-in-publishing data. Edited by Clark SL, Cotton DB, Hankins GD,Phelan JP. 1997; 369-398.
Compendium 2003. ACOG;633-642.
Lockwood CJ. Inheritedthrombophilia in pregnant patients: Detection and treatment paradigm. ObstetGynecol 2002;99:333-341.
Ginsberg JS, Greer I. Useof antithrombotic agents during pregnancy. Chest2001;119:1225-1315.
Related Pages
- Antenatal Corticosteroid Use <34 weeks Gestation
- Antenatal Corticosteroid Use at 34-36 6/7 weeks
- Antibiotic Prophylaxis in Obstetric Procedures
- Delayed Cord Clamping for Newborns
- Diabetic Ketoacidosis
- Endometritis
- Fetal Death / Live Birth Reporting Requirements
- GBS Guidelines
- Hypertensive Disorders of Pregnancy
- Intra-amniotic Infection
- Kleihauer Betke Assay Interpretation
- Magnesium Sulfate for Neuroprotection
- Management of the Third Stage of Labor and Prevention of Postpartum Hemorrhage
- Obstetric Blunt Trauma
- Obstetric Postoperative Venous Thromboembolism Prophylaxis Guidelines
- Placental Examination
- Postpartum Hemorrhage at Vaginal Delivery
- Postpartum Hemorrhage Bundle
- Immediate Postpartum (Post-Placental) IUD Placement
- Management of Second and Third Trimester Pregnancy Loss
- IUFD Checklist – TO BE PLACED ON PATIENT’S CHART
- Preterm PROM
- Pyelonephritis during Pregnancy
- Thromboembolism in Pregnancy